Skip to main content
All insights

Space Exploration Technologies Corp (SPCX) research

Equibles Research on Space Exploration Technologies Corp — analysis and original studies grounded in disclosed primary sources and documented methods.

View SPCX data
Scientific Research November 4, 2026

Who Is Actually Locked Up After an IPO?

We read the lock-up terms in 440 IPO prospectuses from 2024 to 2026. Six months is still the norm, but the biggest deals now release shares early, in most small Nasdaq IPOs only insiders and the largest holders sign, and on the day a lock-up ends the typical stock doesn't fall.

Scientific Research October 27, 2026

Anthropic's S-1 Explains the Unnamed Deals in Google, Broadcom and SpaceX Filings

Alphabet, Broadcom and SpaceX each report a large deal with a private company or customer they don't name. Read against Anthropic's S-1, the amounts, dates and terms match Anthropic's own. Amazon, which does name it, valued the same Anthropic notes $10.7 billion below Anthropic's figure at June 30, and $15.7 billion above it at September 30.

Research Thesis August 18, 2026

SpaceX's $1.8T cap is a two-customer AI bet, with $14.1B in CSAs carrying the entire $100B ARR claim

A Q2-print read on SpaceX as a public company: how $15.8B of the $18.4B Q2 capex flowed into the AI segment, why Customer B at 19.5% and Customer A at 18.3% of revenue sit between the $47.5B backlog and the $100B December ARR target, and how the Cursor close reframes the same concentration risk.

Research Thesis August 5, 2026

Rocket Lab's $2.2B backlog makes the bull case bigger than Neutron

Rocket Lab's record Q1 and $2.2B backlog show the bull case no longer rests on Neutron alone. The proposed Iridium merger could add a recurring-services engine, while financing, dilution and execution remain the price of that upside.

Research Thesis July 16, 2026

Rocket Lab: Backlog is converting, but the $39B market cap is paying for a Neutron debut the company has yet to validate

Rocket Lab enters Q2 2026 with record backlog of $2,219.8M and guided revenue of $225.0M–$240.0M, yet the stock trades at -55.2% from its $150.23 high on a $39.0B market cap against $679.6M of trailing revenue — a gap the equity-funded growth model and the un-flown Neutron debut have to close.